DOXIMITY ($DOCS) is expected to release its quarterly earnings data on Thursday, May 15th after market close, per Finnhub. Analysts are expecting revenue of $136,704,704 and earnings of $0.28 per share.
You can see Quiver Quantitative's $DOCS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
DOXIMITY Insider Trading Activity
DOXIMITY insiders have traded $DOCS stock on the open market 40 times in the past 6 months. Of those trades, 0 have been purchases and 40 have been sales.
Here’s a breakdown of recent trading of $DOCS stock by insiders over the last 6 months:
- JEFFREY TANGNEY (Chief Executive Officer) has made 0 purchases and 10 sales selling 1,003,891 shares for an estimated $75,693,685.
- ANNA BRYSON (Chief Financial Officer) has made 0 purchases and 12 sales selling 290,000 shares for an estimated $18,642,273.
- REGINA M. BENJAMIN has made 0 purchases and 5 sales selling 40,000 shares for an estimated $3,045,882.
- TIMOTHY S CABRAL has made 0 purchases and 3 sales selling 20,000 shares for an estimated $1,152,498.
- KIRA SCHERER WAMPLER has made 0 purchases and 9 sales selling 13,000 shares for an estimated $813,964.
- WATKIN PHOEBE L. YANG sold 2,889 shares for an estimated $217,209
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DOXIMITY Hedge Fund Activity
We have seen 281 institutional investors add shares of DOXIMITY stock to their portfolio, and 179 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DURABLE CAPITAL PARTNERS LP removed 4,933,734 shares (-63.1%) from their portfolio in Q4 2024, for an estimated $263,412,058
- MORGAN STANLEY removed 4,092,452 shares (-76.7%) from their portfolio in Q4 2024, for an estimated $218,496,012
- FMR LLC added 3,874,895 shares (+41.2%) to their portfolio in Q1 2025, for an estimated $224,860,156
- BLACKROCK, INC. added 2,076,304 shares (+17.4%) to their portfolio in Q1 2025, for an estimated $120,487,921
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 1,641,466 shares (-26.4%) from their portfolio in Q1 2025, for an estimated $95,254,271
- ARROWMARK COLORADO HOLDINGS LLC removed 1,395,594 shares (-39.3%) from their portfolio in Q4 2024, for an estimated $74,510,763
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,323,634 shares (+708.7%) to their portfolio in Q4 2024, for an estimated $70,668,819
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DOXIMITY Government Contracts
We have seen $225,793 of award payments to $DOCS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- AMION ON-CALL SCHEDULE FOR HOSPITAL STAFF: $80,000
- PAO'S CONTRACT FOR ONLINE PHYSICIAN ONLY JOB BOARD CAREER LINK THAT CONNECTS EMPLOYERS AND JOBSEEKERS IN TH...: $51,800
- AMION SERVICES: $40,000
- AMION FOR ENTERPRISES: $20,705
- AMION ENTERPRISE LICENSE SUBSCRIPTION - PALO ALTO VAMC: $17,101
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
DOXIMITY Analyst Ratings
Wall Street analysts have issued reports on $DOCS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- KeyBanc issued a "Overweight" rating on 04/16/2025
- Needham issued a "Buy" rating on 02/07/2025
To track analyst ratings and price targets for DOXIMITY, check out Quiver Quantitative's $DOCS forecast page.
DOXIMITY Price Targets
Multiple analysts have issued price targets for $DOCS recently. We have seen 2 analysts offer price targets for $DOCS in the last 6 months, with a median target of $54.0.
Here are some recent targets:
- Stan Berenshteyn from Wells Fargo set a target price of $43.0 on 01/13/2025
- Scott Schoenhaus from KeyBanc set a target price of $65.0 on 01/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.